Pay in 4 interest-free payments of $7.14 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
It helps regulate blood sugar levels by enhancing insulin release, reducing glucagon secretion, and slowing gastric emptying, leading to improved glycemic control Mounjaro Tirzepatide 2.5mg Solution for Injection Request Callback 3590 / Vial Get Latest Price Product Brochure Product Name: Mounjaro 2.5mg/5mg Solution for Injection Brand Name: Mounjaro, Tirzepatide, Lyumjev (Note: Lyumjev is primarily insulin lispro, but associated with Eli Lillys diabetes care portfolio) Composition: Tirzepatide (2.5mg/5mg) Manufacturer/Marketer: Eli Lilly and Company India Pvt Ltd Packaging: To be provided (specify packaging details if available) Treatment: Type 2 diabetes mellitus (to improve glycemic control) Product Description: Mounjaro Solution for Injection contains Tirzepatide, a novel dual GIP and GLP-1 receptor agonist used for the management of type 2 diabetes
Kidney function and electrolytes are periodically rechecked, since significant vomiting or diarrhoea can occasionally affect kidney function
Researchers study it to understand how it helps cells recover and stay balanced, especially under conditions of chemical or oxidative stress
Its anti-inflammatory and restorative properties help address the root causes of these ailments
